MARKET

NTRP

Neurotrope
NTRP
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.8078
-
0.8034
22,387,017.65
News
Financial
Releases
Corp Actions
Analysis
Profile
Neurotrope, Metuchen Pharmaceuticals merge to form new public company
Neurotrope ([[NTRP]]) and Metuchen Pharmaceuticals completes their previously announced merger following the satisfaction of all closing conditions required by the amended merger agreement.Under the terms of the agreement, Neurotrope shareholders also
Seekingalpha · 1d ago
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
PR Newswire · 1d ago
Is Neurotrope, Inc. (NTRP) A Good Stock To Buy According To Hedge Funds?
Insider Monkey · 6d ago
Neurotrope approves spin-off of Neurotrope Bioscience; announces distribution date
Neurotrope’s ([[NTRP]] +3.0%) Board of Directors approved the conditional distribution in connection with the previously announced spin-off of its wholly-owned subsidiary, Neurotrope Bioscience, Inc.Shareholders and certain warrant holders of record
Seekingalpha · 11/20 14:59
Neurotrope, Inc. Board Approves Spin-Off Of Neurotrope Bioscience, Inc.
Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with Metuchen Pharmaceuticals NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ:NTRP) ("Neurotrope"
Benzinga · 11/20 14:01
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates
, /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP) ("Neurotrope" or the "Company") announced today that its Board of Directors has approved the conditional distribution and set the shareholder of record and distribution dates in connection with the previously announced spin-off (the "Spin-Off") of its wholly-owned subsidiary, Neurotrope Bioscience, Inc. ("NBI"). Subject to the closing of Neurotrope's proposed merger with Metuchen Pharmaceuticals, LLC ("Metuchen"), shareholders and certain warrant holders of record of Neurotrope on (the "Record Date") will receive on (the "Distribution Date"), a dividend at the rate of (i) one share of NBI common stock for every five shares of Neurotrope common stock held, (ii) one share of NBI common stock for every five shares of Neurotrope common stock issuable upon conversion of Neurotrope preferred stock held and (iii) one share of NBI common stock for every five shares of Neurotrope common stock issuable upon exercise of certain Neurotrope warrants held that are entitled to participate in the spin-off pursuant to the terms thereof (collectively, the "Distribution"). Any fractional shares will be paid in cash. Neurotrope and Metuchen previously announced their intent to merge in an all-stock transaction resulting in the formation of a holding company to be named Petros Pharmaceuticals, Inc. ("Petros"), which expects to trade on the Nasdaq Capital Market under the symbol "PTPI" following the closing of the merger.  Neurotrope's meeting of shareholders to approve the proposed merger and other matters is scheduled for , 2020. 
PR Newswire - PRF · 11/20 14:00
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates
Neurotrope, Inc. (NASDAQ: NTRP) ("Neurotrope" or the "Company") announced today that its Board of Directors has approved the conditional distribution and set the shareholder of record and distribution dates in connection with the previously announced spin-off (the "Spin-Off") of its wholly-owned subsidiary, Neurotrope Bioscience, Inc. ("NBI"). Subject to the closing of Neurotrope's proposed merger with Metuchen Pharmaceuticals, LLC ("Metuchen"), shareholders and certain warrant holders of record of Neurotrope on November 30, 2020 (the "Record Date") will receive on December 7, 2020 (the "Distribution Date"), a dividend at the rate of (i) one share of NBI common stock for every five shares of Neurotrope common stock held, (ii) one share of NBI common stock for every five shares of Neurotrope common stock issuable upon conversion of Neurotrope preferred stock held and (iii) one share of NBI common stock for every five shares of Neurotrope common stock issuable upon exercise of certain Neurotrope warrants held that are entitled to participate in the spin-off pursuant to the terms thereof (collectively, the "Distribution"). Any fractional shares will be paid in cash. Neurotrope and Metuchen previously announced their intent to merge in an all-stock transaction resulting in the formation of a holding company to be named Petros Pharmaceuticals, Inc. ("Petros"), which expects to trade on the Nasdaq Capital Market under the symbol "PTPI" following the closing of the merger. Neurotrope's meeting of shareholders to approve the proposed merger and other matters is scheduled for November 25, 2020.
PR Newswire · 11/20 14:00
Insider Buys Neurotrope Stock
A Form 4 filing filed with the SEC on Thursday, October 22 showed that Schechter Jonathan bought 2,012 shares of Neurotrope Inc (NASDAQ:NTRP) at $1.10 on Tuesday, Oct 20, and bought 22,988 shares at $1.10 on Wednesday, Oct 21.The transaction moved the executive's stake in Neurotrope Inc. to 2,012 shares. Shares of Neurotrope moved higher by 0.90% from the previous closing price.Why Insider Transactions Are Important? Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.When an insider buys stock after an important sell off, that can indicate the insider's faith in the success of the organization. Henceforth, if the stock is bought at new highs, it might be because the insider feels that the stock is not overvalued. Insiders who sell stock at new lows could be anticipating some capitulation moment. If the insider sells at new highs, it could point to the intention to "take some profit" and "lock in a gain."Transaction Codes To Focus On Investors prefer focusing on transactions which take place in the open market, indicated in the Form 4 with codes P for purchase and S for sale. If the transaction was an open-market transaction, that means that the insider made a concious decision for the company's stock moving forward.Transaction codes besides P or S aren't relatively important as they are seldom tied to a decision by the executive. For example, transaction code A is indicative of an insider being forced to sell shares to attain compensation. Moreover, transaction code C indicates the conversion of an option. See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Insider Buys Neurotrope's Stock * Insider Buys Neurotrope's Shares(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 10/22 17:04
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NTRP. Analyze the recent business situations of Neurotrope through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NTRP stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 56
Institutional Holdings: 2.70M
% Owned: 11.34%
Shares Outstanding: 23.79M
TypeInstitutionsShares
Increased
8
137.54K
New
8
-33.54K
Decreased
4
19.85K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now

Webull offers kinds of Neurotrope stock information, including NASDAQ:NTRP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTRP stock methods without spending real money on the virtual paper trading platform.